Corvus Pharmaceuticals, Inc. short interest in 2021
In 2021, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 4.40% of shares outstanding on 15 Jan 2021 to 0.48% on 31 Dec 2021, a change of -3.92 percentage points. The year's high was 5.64% on 15 Mar 2021 and its low 0.48% on 31 Dec 2021, averaging 3.11% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.04 days on 30 Apr 2021. Full history: Corvus Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 4.40% (15 Jan 2021)
- End of year
- 0.48% (31 Dec 2021)
- Change
- -3.92 pp
- High
- 5.64% (15 Mar 2021)
- Low
- 0.48% (31 Dec 2021)
- Average
- 3.11%
- Highest days to cover
- 8.04 (30 Apr 2021)
- SEC filings marked
- 10
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 4.40% | 7.95 | |
| 29 Jan 2021 | 4.39% | 5.55 | |
| 12 Feb 2021 | 4.41% | 1.79 | results (8-K) |
| 26 Feb 2021 | 4.54% | 1.00 | |
| 15 Mar 2021 | 5.64% | 1.95 | |
| 31 Mar 2021 | 3.79% | 2.89 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 3.50% | 5.73 | |
| 30 Apr 2021 | 3.44% | 8.04 | 10-Q filed, results (8-K) |
| 14 May 2021 | 3.13% | 1.45 | |
| 28 May 2021 | 3.24% | 5.58 | |
| 15 Jun 2021 | 2.96% | 7.58 | |
| 30 Jun 2021 | 3.16% | 6.16 | |
| 15 Jul 2021 | 3.19% | 6.41 | results (8-K) |
| 30 Jul 2021 | 3.29% | 3.54 | |
| 13 Aug 2021 | 2.30% | 4.40 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 1.20% | 2.60 | |
| 15 Sep 2021 | 1.73% | 2.57 | |
| 15 Oct 2021 | 4.19% | 1.00 | |
| 29 Oct 2021 | 4.34% | 2.81 | |
| 15 Nov 2021 | 2.25% | 1.09 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 1.22% | 1.00 | |
| 15 Dec 2021 | 0.70% | 1.00 | |
| 31 Dec 2021 | 0.48% | 1.00 |
See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.